StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4299.T$1125.00-0.27%
Fair $1125.00+0.0%

4299.T

HIMACS, Ltd.

Technology / Software - ApplicationTokyo

$1125.00

-3.00 (-0.27%)

Fairly Valued+0.0%Fair Value $1125.00Fund rank 32/100 · Data gapFallback financials|
SA 33/D
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.4B · quality 61.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 76/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 4299.TLocal privado en este navegador · HIMACS, Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$11.7B

P/E

11.1x

↓

EV/EBITDA

2.0x

↓

ROE

11.0%

↑

Gross Margin

20.2%

↓

Debt/Equity

N/A

•
52-Week Range$1125
$1111$1378

TradingView lightweight chart

4299.T price, volumen y niveles de valoración

Último $1,125Periodo +69.8%
Fair value: $1,125

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+2.7%

FCF CAGR

-6.4%

FCF margin

4.1%

FCF / Net income

0.57x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $18.07B · net income $1.29B · FCF $739.0M

2022-FY → 2025-FY

Gross margin

20.2%+0.3% pts

Operating margin

10.0%-0.3% pts

Net margin

7.2%-0.1% pts

FCF margin

4.1%-1.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$18.07B$18.07B$17.36B$17.33B$16.68B
Net Income$1.29B$1.29B$1.18B$1.29B$1.21B
EBITDA$1.82B$1.82B$1.76B$1.88B$1.77B
EPS111.59111.59101.89111.27104.63
Gross Margin20.2%20.2%20.4%20.0%19.8%
Operating Margin10.0%10.0%9.9%10.6%10.3%
Net Margin7.2%7.2%6.8%7.5%7.3%
Balance Sheet
Current Ratio5.005.00———
Cash Flow
Free Cash Flow$739.0M$739.0M$1.39B$1.58B$902.0M
Returns
ROE11.0%11.0%10.8%12.5%12.8%
Valuation
P/E11.0711.0713.8312.6212.55
EV/EBITDA1.951.953.714.184.44
P/B1.111.111.501.581.60
Growth & Yield
Revenue Growth4.1%4.1%0.2%3.9%—
EPS Growth9.5%9.5%-8.4%6.3%—
Dividend Yield4.1%4.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-3.6%

fácil

EPS terminal req.

$99.83

Spread vs growth

13.2%

5Y implied EPS CAGR

1.6%

fácil

EPS terminal req.

$120.79

Spread vs growth

7.9%

10Y implied EPS CAGR

5.7%

razonable

EPS terminal req.

$194.53

Spread vs growth

3.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.1%

Total return

+0.1%

Start / end P/E

11.5x → 10.1x

EPS bridge

101.89 → 111.59

Residual

-1.2%

EPS growth+9.5%
Multiple rerating-12.4%
Dividend+4.1%
Residual / FX / buybacks / cross-term-1.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.